The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.715
Bid: 0.65
Ask: 0.70
Change: 0.09 (14.40%)
Spread: 0.05 (7.692%)
Open: 0.625
High: 0.715
Low: 0.715
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

31 Jan 2012 07:00

RNS Number : 4379W
Ultima Networks PLC
31 January 2012
 



 

Ultima Networks plc

("Ultima" or the "Group")

Trading Update

31st January 2012

Ultima, the IT and Green Technology Company, is pleased to provide an update on trading following the end of its financial year on 31 December 2011.

 

The Board of Ultima are pleased to announce that it has seen growth in all of its operating divisions during the year ended 31 December 2011 and that it expects to report turnover and net profit ahead of market expectations. The Group operates through three divisions: IT Services, Green technology products and Green power. These divisions are involved respectively in the sale of software to the legal profession, the development and sale of specialist electrical goods and the development of clean power generation through solar installations in Spain, Italy and the United Kingdom.

 

The IT Services division provides computer application software and related support and other services to small and medium size legal practices in England and Wales. The division operates under the name Cognito Software Limited and during the year launched its latest integrated legal software suite which is marketed under the name "FiLos". The introduction of FILOS marketed alongside the existing software range is expected to attract interest from larger legal practices and spearhead the continued growth in the division's profitability.

The Green technology products division has seen continued growth in its range of electrically powered bicycles marketed under the brand names "Powacycle" and "Infineum". Significant sales growth in continental Europe more than compensated for the difficult market conditions for luxury goods in the UK. The division accounted for 58% of sales in 2011, is expected to increase in 2012 led by the introduction of new models, continued R&D activity and targeted marketing.

The Green power division completed over 500 KW of solar photovoltaic installations throughout the UK during 2011. It has retained ownership of 400 KW for future sale; in the meantime the generating capacity retained by the division will contribute to an increase in recurring revenue received under the "FITS" (Feed in tariff) programme estimated at £120,000 per annum. The installations met the 12th December 2011 deadline (set by the government in order to receive the higher tariff for the 25 year life of the scheme). The division is currently expanding its operations to include the Renewable Heat Installations using Ground Source Heat pumps, where the Feed in Tariff is currently available to commercial organisations and expected to be extended to domestic consumers by October 2012. The investment made into a 100KW solar park in Spain is operating and expected to increase its contribution to the division's revenue during 2012.

The continued investments in new technology with a strong R&D effort reinforces the company's focus on achieving growth and profitability through the introduction of new products and continuous attention to the company's competitive position.

Ultima also announces that on 19 September 2011 it transferred its trading platform from SEAQ to SETSqx (Stock Exchange Electronic Trading Service- quotes and crosses). SETSqx combines the existing non-electronic market maker quote with periodic electronic auctions designed to concentrate liquidity. The auctions allow both market makers and non-market makers to enter electronic limit orders and to participate in the auctions.

The Board of Ultima expects to release its results for the year ended 31st December 2011 during May 2012.

Enquires:

Ultima Networks plc 01279 821200

Prof. Humayun Mughal, Chairman and CEO

 

Allenby Capital Limited (nominated adviser and broker) 0203 328 5656

Nick Athanas

Dan Robinson

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSDFEDSFESEDF
Date   Source Headline
16th Mar 202010:26 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSPosting of Annual Report and Notice of AGM
25th Feb 20207:00 amRNSFinal Results
11th Feb 20207:00 amRNSResearch Collaboration Agreement
29th Jan 20207:00 amRNSUpdate on Nuvec® process improvements
18th Sep 20197:00 amRNSInterim Results
20th Aug 20197:00 amRNSResults of University of Queensland Study
13th Aug 201911:16 amRNSHolding(s) in Company
15th Jul 20192:05 pmRNSSecond Price Monitoring Extn
15th Jul 20192:00 pmRNSPrice Monitoring Extension
3rd Jul 20194:40 pmRNSSecond Price Monitoring Extn
3rd Jul 20194:35 pmRNSPrice Monitoring Extension
19th Jun 201912:51 pmRNSResult of AGM
19th Jun 20197:00 amRNSAGM Statement
14th Jun 20194:41 pmRNSSecond Price Monitoring Extn
14th Jun 20194:36 pmRNSPrice Monitoring Extension
28th May 20192:21 pmRNSChange to Director Shareholding
22nd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
21st May 20197:00 amRNSBoard Changes
14th May 20197:00 amRNSFinal Results
15th Apr 20197:00 amRNSNuvec® Research update
10th Apr 201911:52 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSNuvec® Research update
20th Mar 20199:40 amRNSHolding(s) in Company
20th Mar 20199:40 amRNSHolding(s) in Company
28th Feb 20195:00 pmRNSTotal Voting Rights
14th Feb 20192:14 pmRNSHolding(s) in Company
8th Feb 201912:23 pmRNSPlacing to raise £1.05 million
20th Dec 20187:00 amRNSNuvec licence extension
28th Nov 20187:00 amRNSNuvec® research update
16th Nov 20181:36 pmRNSNuvec resource changes
15th Nov 20187:00 amRNSFiling of further Nuvec® patent application
14th Nov 201811:05 amRNSSecond Price Monitoring Extn
14th Nov 201811:00 amRNSPrice Monitoring Extension
14th Nov 20189:05 amRNSSecond Price Monitoring Extn
14th Nov 20189:00 amRNSPrice Monitoring Extension
8th Nov 20184:40 pmRNSSecond Price Monitoring Extn
8th Nov 20184:35 pmRNSPrice Monitoring Extension
8th Nov 20182:05 pmRNSSecond Price Monitoring Extn
8th Nov 20182:00 pmRNSPrice Monitoring Extension
5th Nov 201811:06 amRNSSecond Price Monitoring Extn
5th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSPrice Monitoring Extension
5th Nov 20187:54 amRNSResearch collaboration update
29th Oct 20187:00 amRNSNuvec® research update
2nd Oct 201811:44 amRNSResearch collaboration for novel DNA vaccine
26th Sep 20181:48 pmRNSGrant of options
26th Sep 201811:00 amRNSPrice Monitoring Extension
24th Sep 20184:41 pmRNSSecond Price Monitoring Extn
24th Sep 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.